KCNH3 Loss-of-Function Variant Associated with Epilepsy and Neurodevelopmental Delay Enhances Kv12.2 Channel Inactivation

@article{Bauer2025KCNH3LV,
 title={KCNH3 Loss-of-Function Variant Associated with Epilepsy and Neurodevelopmental Delay Enhances Kv12.2 Channel Inactivation},
 author={Christiane K. Bauer and Arne Bilet and Frederike Leonie Harms and Robert B{\"a}hring},
 journal={International Journal of Molecular Sciences},
 year={2025},
 volume={26},
 url={https://api.semanticscholar.org/CorpusID:278607324}
}
Kv12.2 data show similarities to Kv11 channels regarding C-type inactivation and differences regarding the sensitivity to external K+ and pharmacological inhibition of inactivation, as well as similarities to Kv11 channels regarding C-type inactivation and differences regarding the sensitivity to external K+ and pharmacological inhibition of inactivation.

64 References

Most LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism

This is the first study to identify a dominant mechanism, class 2, for the loss of Kv11.1 channel function in LQT2 and to report that the class 2 phenotype for many of these mutant channels can be corrected, which suggests that if therapeutic strategies to correct protein trafficking abnormalities can be developed, it may offer clinical benefits for L QT2 patients.

Tuning of EAG K+ channel inactivation: Molecular determinants of amplification by mutations and a small molecule

It is shown that human EAG1 channels exhibit an intrinsic voltage-dependent slow inactivation that is markedly enhanced in rate and extent by 1–10 μM 3-nitro-N-(4-phenoxyphenyl) benzamide, or ICA105574 (ICA).

KCNE1 and KCNE3 β-Subunits Regulate Membrane Surface Expression of Kv12.2 K+ Channels In Vitro and Form a Tripartite Complex In Vivo

It is demonstrated that the auxiliary MinK (KCNE1) and MiRP2 (KC NE3) proteins are important regulators of Kv12.2 channel function and Native co-immunoprecipitation assays from mouse brain membranes imply that KCNE1 and KCNE3 interact with Kv 12.2 channels to regulate channel membrane trafficking.

Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome

It is demonstrated that KCNH1 mutations cause ZLS and genetic heterogeneity for this disorder is documented, and structural analysis predicts a perturbing effect of the mutation on complex assembly.

Distribution and functional properties of human KCNH8 (Elk1) potassium channels.

Quantitative RT-PCR analysis of mRNA expression patterns showed that KCNH8, along with the other Elk family genes, KCNH3 and KCNH4, are primarily expressed in the human nervous system, and thatKCNH8 subunits are not able to form heteromultimers with Eag, Erg, or Kv family K+ channels.

Molecular mechanism of voltage-dependent potentiation of KCNH potassium channels

It is proposed that the activation of ELK channels involves a slow open-state dependent rearrangement of the direct interaction between the eag domain and CNBHD, which stabilizes the opening of the channel.

Association of the hERG mutation with long-QT syndrome type 2, syncope and epilepsy

A heterozygous missense mutation linked to LQT2, syncope and epilepsy was identified in the S5/pore region of the hERG protein, and exerts a potent dominant-negative effect on WT-hERG channels, resulting in decreased hERG currents and impairment of hERG membrane localization.
...